A0A024R2F2 (A0A024R2F2_HUMAN) Homo sapiens (Human)

von Hippel-Lindau tumor suppressor isoform 2 UniProtKBInterProInteractive Modelling

213 aa; Sequence (Fasta) ; 4 identical sequences: Homo sapiens: P40337; Pan troglodytes: K7BID8, A0A6D2WU70; Pan paniscus: A0A2R9B5S8

Available Structures

110 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P40337; P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
54-213
100
FAK Protac GSK215 in complex with FAK and pVHL:ElonginC:ElonginB Heteromer
P40337; Q05397; Q15369; Q15370;
59-213
1007QB;PEG; 14×EDO;CA;
The complex structure of Cul2-VCB-Protac-Wee1 Heteromer
P30291; P40337; P62877; Q13617; Q15369; Q15370;
59-213
100W6U;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker Heteromer
P40337; P61964; Q15369; Q15370;
57-210
10010×SCN;Q43;EDO;K;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1) Heteromer
P40337; P61964; Q15369; Q15370;
57-209
10015×SCN; 13×EDO;P6G;Q3X;
BRG1 bromodomain in complex with VBC via compound 17 Heteromer
P40337; P51532; Q15369; Q15370;
61-213
100PO4;GOL;VLH;
Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
59-210
100FX8; 11×EDO;FMT;
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15370; Q2KII4; Q99814;
60-210
100GOL;
PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL Heteromer
P40337; Q07817; Q15369; Q15370;
59-209
100QL8; 17×EDO;GOL; 12×IOD;
Crystal structure of compound 6 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:… Heteromer
P40337; P51531; Q15369; Q15370;
60-210
100IFF;
Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C Heteromer
P40337; Q15369; Q15370; Q99814;
59-209
100
Crystal structure of VHL in complex with H313, a Helicon Polypeptide Heteromer
P40337; Q15369; Q15370;
58-208
100WHL;
Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex Heteromer
P40337; Q15369; Q15370; Q16665;
60-209
100
Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B compl… Heteromer
P40337; Q15369; Q15370; Q16665;
61-210
100SO4;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #2) Heteromer
P40337; P61964; Q15369; Q15370;
58-207
100SCN;Q3X;EDO;
CRYSTAL STRUCTURE OF AT7 IN COMPLEX WITH THE SECOND BROMODOMAIN OF HUMAN BRD4 AND PVHL:ELONGINC:ELO… Heteromer
O60885; P40337; Q15369; Q15370;
61-210
100IZR;
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370; Q16665;
60-208
100SO4;F4K;GOL;
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:El… Heteromer
P40337; P51532; Q15369; Q15370;
61-209
100FWZ;DMS;
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15369; Q15370; Q99814;
60-208
100FMT;
Crystal structure of the complex between VHL, ElonginB, ElonginC, and compound 5 Heteromer
P40337; Q15369; Q15370;
61-209
100EDO;DMS;CL;A1ARP;
Crystal structure of PROTAC 5 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
61-209
100IEI;
Crystal Structure of ligand ACBi1 in complex with bromodomain of human Smarca2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
60-208
100EDO;NA;PEG;87A;
Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48 Heteromer
P40337; Q15369; Q15370;
59-207
100SYF;
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
60-208
100EDO;FWZ;EPE;
Ternary complex between VCB, BRD4-BD2 and PROTAC 51 Heteromer
O60885; P40337; Q15369; Q15370;
61-209
100QLX;
The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB Heteromer
O60885; P40337; Q15369; Q15370;
61-209
100759;
SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC Heteromer
P40337; Q13451; Q15369; Q15370;
61-209
100XZW;
Ternary complex between VCB, BRD4-BD2 and PROTAC 48 Heteromer
O60885; P40337; Q15369; Q15370;
61-209
100QIY;
E3:PROTAC:target ternary complex structure (VCB/WH244/BCL-2) Heteromer
P10415; P40337; Q15369; Q15370;
60-208
100YFH;
Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … Heteromer
O60885; P40337; Q15369; Q15370;
61-209
100LFE;
Ubiquitin ligation to neosubstrate by a cullin-RING E3 ligase & Cdc34: NEDD8-CUL2-RBX1-ELOB/C-VHL-M… Heteromer
O60885; P0CG48; P40337; P62877; Q13617; Q15369; Q15370; Q712K3;
61-209
100ZN;SY8;759;
Crystal structure of Protac MS33 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P40337; P61964; Q15369; Q15370;
58-205
100SCN;EDO;VKA;GOL;NA;
von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide Heteromer
P40337; Q15369; Q15370; Q16665;
60-207
100GOL;
Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… Heteromer
O60885; P40337; Q15369; Q15370;
61-208
100WEP;
VCB in complex with compound 27 Heteromer
P40337; Q15369; Q15370;
62-209
100QF3;
Crystal Structure of compound 4 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; P40337; Q15369; Q15370;
60-207
100X53;GDP;MG;
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 8 molecular glue Heteromer
P40337; Q15369; Q15370; Q16878;
61-208
100A1ACI;CIT;FE2;
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 4 molecular glue Heteromer
P40337; Q15369; Q15370; Q16878;
61-208
1003JF;CIT;FE2;
VHL/Elongin B/Elongin C complex with compound 155 Heteromer
P40337; Q15369; Q15370;
61-208
100VL6;
Structure of VHL-EloB-EloC-Cul2 Heteromer
P40337; Q13617; Q15369; Q15370;
60-207
100
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P40337; P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
60-207
100ZN;
(NEDD8)-CRL2VHL-MZ1-Brd4BD2-Ub(G76S, K48C)-UBE2R1(C93K, S138C, C191S, C223S)-Ub Heteromer
O60885; P0CG48; P40337; P49427; P62877; Q13617; Q15369; Q15370; Q15843;
61-208
100759;ZN;
Ternary complex between VCB, BRD4-BD1 and PROTAC 48 Heteromer
O60885; P40337; Q15369; Q15370;
61-207
100SO4;EDO;QIY;
pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxypr… Heteromer
P40337; Q15369; Q15370; Q16665;
61-207
100
Crystal structure of pVHL:EloB:EloC in complex with MP-1-21 Heteromer
P40337; Q15369; Q15370;
61-207
100A1H9F;
Quaternary Complex of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC Homer Heteromer
P40337; P61964; Q15369; Q15370;
59-205
1008KH;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with C3 linker Heteromer
P40337; P61964; Q15369; Q15370;
62-208
100Q3R;
VHL recognizes hydroxyproline in RIPK1 Heteromer
P40337; Q13546; Q15369; Q15370;
60-206
100
E3:PROTAC:target ternary complex structure (VCB/753b/BCL-xL) Heteromer
P40337; Q07817; Q15369; Q15370;
61-207
100CAD;GOL;YF8;
Crystal structure of the VCB complex with compound 1. Heteromer
P40337; Q15369; Q15370;
62-207
100WBN;CL;
VCB in complex with compound 32 Heteromer
P40337; Q15369; Q15370;
62-207
100QF7;
Co-crystal structure of Compound 11 in complex with the bromodomain of human SMARCA2 and pVHL:Elong… Heteromer
P40337; P51531; Q15369; Q15370;
60-205
100GOL;FWZ;
DNA-encoded library (DEL)-enabled discovery of proximity inducing small molecules Heteromer
O60885; P40337; Q15369; Q15370;
61-206
100X5K;
Open non-crosslinked structure Brd4BD2-MZ1-(NEDD8)-CRL2VHL Heteromer
O60885; P40337; P62877; Q13617; Q15369; Q15370;
63-208
100759;ZN;
VCB in complex with compound 30 Heteromer
P40337; Q15369; Q15370;
62-206
100QE0;
Crystal structure of the complex between VHL, ElonginB, ElonginC, and compound 5 Heteromer
P40337; Q15369; Q15370;
61-205
100.0TFA;PEG;EDO;ACT;
VCB in complex with compound 23 Heteromer
P40337; Q15369; Q15370;
62-206
100QFR;
Crystal Structure of compound 3 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; P40337; Q15369; Q15370;
61-204
100GDP;X4R;MG;
Crystal Structure of ligand ACBI3 in complex with KRAS G12D C118S GDP and pVHL:ElonginC:ElonginB co… Heteromer
P01116; P40337; Q15369; Q15370;
61-204
100WYL;GDP;MG;
E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2) Heteromer
P10415; P40337; Q15369; Q15370;
61-204
100YF8;
Crystal structure of compound 10 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC… Heteromer
P40337; P51531; Q15369; Q15370;
60-202
100IOD;IFJ;
VCB in complex with compound 26 Heteromer
P40337; Q15369; Q15370;
62-204
100QE9;
Crystal structure of pVHL:EloB:EloC in complex with MP-1-39 Heteromer
P40337; Q15369; Q15370;
62-204
100A1H6O;
Crystal structure of Protac MS67 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P40337; P61964; Q15369; Q15370;
62-204
100GOL;X6M;
pVHL:EloB:EloC in complex with (2S,4R)-N-((S)-1-(5-Fluoro-2-methoxy-4-(4-methylthiazol-5-yl)phenyl)… Heteromer
P40337; Q15369; Q15370;
62-204
100VH3;
pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzy… Heteromer
P40337; Q15369; Q15370;
62-204
100.0GOL;ZUN;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
62-204
100VYQ;
VCB in complex with compound 21 Heteromer
P40337; Q15369; Q15370;
62-204
100QFF;
Co-crystal structure of Compound 1 in complex with the bromodomain of human SMARCA4 and pVHL:Elongi… Heteromer
P40337; P51532; Q15369; Q15370;
62-204
100NA;YHB;PEG;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y… Heteromer
P40337; Q15369; Q15370;
62-203
100.03JU;
pVHL:EloB:EloC in complex with VH298 Heteromer
P40337; Q15369; Q15370;
62-203
1006Z3;
pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisox… Heteromer
P40337; Q15369; Q15370;
63-204
100.0TR0;
THE VHL-ELONGINC-ELONGINB STRUCTURE Heteromer
P40337; Q15369; Q15370;
63-204
100
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370;
62-203
1009BN;
pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyr… Heteromer
P40337; Q15369; Q15370;
63-204
100.0ZTD;
pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidany… Heteromer
P40337; Q15369; Q15370;
62-203
100.0ACT;UCK;
pVHL54-213-EloB-EloC complex_apo Heteromer
P40337; Q15369; Q15370;
63-204
100
pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL… Heteromer
P40337; Q15369; Q15370;
63-204
100L8B;
pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)ben… Heteromer
P40337; Q15369; Q15370;
62-202
100.0TG0;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hy… Heteromer
P40337; Q15369; Q15370;
62-202
1009BH;
pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl… Heteromer
P40337; Q15369; Q15370;
62-202
1009BT;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-m… Heteromer
P40337; Q15369; Q15370;
62-202
1003JF;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370;
62-202
1003JO;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hyd… Heteromer
P40337; Q15369; Q15370;
62-202
1009B8;
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-… Heteromer
P40337; Q15369; Q15370;
62-202
100.0X6C;ACT;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)… Heteromer
P40337; Q15369; Q15370;
62-202
1003JG;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl… Heteromer
P40337; Q15369; Q15370;
62-202
1003JK;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-h… Heteromer
P40337; Q15369; Q15370;
62-202
1009BW;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370;
62-202
1004YY;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370;
62-202
1003JH;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimeth… Heteromer
P40337; Q15369; Q15370;
62-202
1003JJ;
pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370;
62-202
100EXE;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
62-202
1009BK;
pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydro… Heteromer
P40337; Q15369; Q15370;
62-202
1003JS;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthi… Heteromer
P40337; Q15369; Q15370;
62-202
100DV5;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl… Heteromer
P40337; Q15369; Q15370;
62-202
1003JT;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-… Heteromer
P40337; Q15369; Q15370;
62-202
1003JV;
pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370;
62-202
100EXH;
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370;
62-202
100DV8;
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370;
62-202
100DV2;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
62-202
100VFO;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol… Heteromer
P40337; Q15369; Q15370;
62-202
1009B5;
Ternary complex between VCB, BRD4-BD1 and PROTAC 49 Heteromer
O60885; P40337; Q15369; Q15370;
62-202
100SO4;QIK;
pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate Heteromer
P40337; Q15369; Q15370;
62-201
100.0ACT;F4E;
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methy… Heteromer
P40337; Q15369; Q15370;
62-201
100.0QD0;
pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one Heteromer
P40337; Q15369; Q15370;
62-201
100.0F7B;IPA;
pVHL:EloB:EloC complex, in complex with capped Hydroxyproline Heteromer
P40337; Q15369; Q15370;
62-200
100.0ACT;V6F;
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370;
63-201
100.0
PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1 Heteromer
P01116; P40337; P62877; Q13617; Q15369; Q15370;
66-204
100ZN;GDP;WYL;
Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex Heteromer
P40337; P62877; Q13617; Q15369; Q15370;
157-193
100ZN;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4wqo.1.Amonomer0.8460-207
100.00